Send me a link:

*Text messaging rates may apply.

 Dow Up 0.36% Nasdaq Up 0.71%

More On PGLA

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Progen Pharmaceuticals Limited (PGLA)

-Other OTC
1.45 0.75(107.14%) Jul 22, 3:59PM EDT
Prev Close:0.70
Open:0.88
Bid:N/A
Ask:N/A
1y Target Est:4.00
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.75 - 1.86
52wk Range:0.12 - 1.86
Volume:81,165
Avg Vol (3m):6,100
Market Cap:80.16M
P/E (ttm):N/A
EPS (ttm):-0.06
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

ยป More Headlines for PGLA

Comparison

Symbol% ChgMkt Cap
PGLAUp 107.14%80.16M
PFE194.49B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.54
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-07) :N/A
Quarterly EPS Est (Jun-07) :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Progen Pharmaceuticals Limited, a biotechnology company, discovers, researches, and develops biopharmaceutical therapeutics for the treatment of human diseases in Australia and the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback